Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Friedreich Ataxia is a rare, inherited neurodegenerative disorder caused by a specific genetic mutation in the FXN gene that prevents the body from producing enough frataxin, a protein essential for mitochondrial function. This deficiency leads to a buildup of cellular stress and damage, primarily affecting the nervous system and heart. What is the primary genetic cause of Friedreich Ataxia? The fundamental cause of Friedreich Ataxia is a mutation in the FXN gene located on chromosome 9.
TL;DR: Friedreich Ataxia is a rare, inherited neurodegenerative disorder caused by a specific genetic mutation in the FXN gene that prevents the body from producing enough frataxin, a protein essential for mitochondrial function. This deficiency leads to a buildup of cellular stress and damage, primarily affecting the nervous system and heart.
The fundamental cause of Friedreich Ataxia is a mutation in the FXN gene located on chromosome 9. In healthy individuals, this gene contains a small segment of DNA—known as a GAA trinucleotide repeat—that is repeated between 5 and 33 times. In individuals with Friedreich Ataxia, this segment is abnormally expanded, often repeating between 66 and over 1,000 times. This expansion acts like a "stutter" in the genetic code, causing the cell to struggle to produce sufficient levels of a protein called frataxin. Because frataxin is vital for the health of mitochondria—the energy-producing "power plants" of our cells—the resulting deficiency leads to energy failure and oxidative stress, which particularly damages nerve and muscle cells.
Yes, Friedreich Ataxia is an autosomal recessive genetic disorder. This means that an individual must inherit two copies of the mutated FXN gene—one from each parent—to develop the condition. Parents who each carry one mutated gene copy (but do not have the disease themselves) are considered "carriers." Each child of two carrier parents has a 25% chance of inheriting both mutated copies and developing Friedreich Ataxia. Because this is a genetic condition, there are no known environmental triggers or lifestyle factors that cause the disease to develop; it is determined at the moment of conception.
When frataxin levels are critically low, the cellular machinery fails to manage iron properly within the mitochondria. This creates a cascade of metabolic issues that contribute to the progression of Friedreich Ataxia:
While the primary genetic cause of Friedreich Ataxia is well-established, medical researchers are still actively investigating why the severity and age of onset vary so significantly between patients. For instance, the length of the GAA repeat expansion often correlates with the age of onset; longer expansions are generally associated with an earlier onset and more rapid progression. However, other genetic modifiers and individual biological differences are currently being studied to explain why two people with similar genetic profiles may experience the disease differently. Current research is heavily focused on gene therapies and small-molecule drugs designed to increase frataxin production or bypass the mitochondrial defect entirely.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.